Literature DB >> 1686113

The cardiovascular system and daily variation in response to antihypertensive and antianginal drugs: recent advances.

B Lemmer1.   

Abstract

This review contains recent data on the pharmacokinetics and the hemodynamic effects on heart rate and blood pressure of three different groups of drugs (beta-blockers: propranolol; oral nitrates: isosorbide-dinitrate (ISDN), isosorbide-5-mononitrate (IS-5-MN); calcium channel blockers: nifedipine) which were investigated in healthy volunteers or in hypertensive patients after drug application at different times of the day. In the case of IS-5-MN and nifedipine two different galenic formulations were studied. The results clearly demonstrate chronopharmacokinetics for propranolol, ISDN, and the immediate-release formulations of IS-5-MN and nifedipine, whereas no pharmacokinetic daily variations were observed with the sustained-release formulations. However, all drugs exhibited daily variations in their hemodynamic effects. These data greatly support the view that pharmacokinetics and drug effects should be studied simultaneously when chronopharmacologic studies are performed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686113     DOI: 10.1016/0163-7258(91)90082-w

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  3 in total

1.  Pharmacokinetics of traditional Chinese syndrome and recipe: a hypothesis and its verification (I).

Authors:  Xi Huang; Ping Ren; Ai-Dong Wen; Li-Li Wang; Li Zhang; Feng Gao
Journal:  World J Gastroenterol       Date:  2000-06       Impact factor: 5.742

Review 2.  Chronopharmacokinetics. Are they clinically relevant?

Authors:  B Lemmer; B Bruguerolle
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

Review 3.  The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.

Authors:  J S Grundy; R T Foster
Journal:  Clin Pharmacokinet       Date:  1996-01       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.